Concomitant Administration of FSH With a Low Dose of hCG (1,500 IU) Has Equivalent Oocyte Developmental Competence While Decreasing the Exposure to hCG in IVF Cycles: A Double Blind Randomized Control Trial

Next Previous
Trial Profile

Concomitant Administration of FSH With a Low Dose of hCG (1,500 IU) Has Equivalent Oocyte Developmental Competence While Decreasing the Exposure to hCG in IVF Cycles: A Double Blind Randomized Control Trial

Recruiting
Phase of Trial: Phase III

Latest Information Update: 13 Jan 2017

At a glance

  • Drugs Chorionic gonadotropin (Primary) ; Urofollitropin (Primary)
  • Indications Female infertility
  • Focus Therapeutic Use

    • Most Recent Events

    • 09 Jan 2017 Planned End Date changed from 1 May 2017 to 1 Jul 2017.
    • 01 Jul 2016 Planned End Date changed from 1 Dec 2016 to 1 May 2017.
    • 01 Jul 2016 Planned primary completion date changed from 1 Jun 2016 to 1 May 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top